Stay updated with breaking news from John Lambert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amplia Therapeutics Ltd (ASX:ATX) is poised to begin the recruiting for a Phase 2 clinical trial concerning its Focal Adhesion Kinase (FAK) inhibitor,...
Amplia Therapeutics Ltd (ASX:ATX)'s Dr John Lambert discusses with Proactive a positive outcome from a pre-Investigational New Drug (pre-IND) meeting with...
"In my class of about 800 students, 18 were women and six were Black: five men and me."
Amplia Therapeutics Ltd (ASX:ATX) has begun pre-Investigational New Drug (pre-IND) interaction and discussion with the United States Food and Drug...
From cantatas to concertos, Michael White looks over the artist's ever-evolving musical voice